These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32422377)

  • 1. Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population.
    Auer ED; Tong HV; Amorim LM; Malheiros D; Hoan NX; Issler HC; Petzl-Erler ML; Beltrame MH; Boldt ABW; Toan NL; Song LH; Velavan TP; Augusto DG
    Int J Infect Dis; 2020 Jul; 96():541-547. PubMed ID: 32422377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.
    Yindom LM; Mendy M; Bodimeade C; Chambion C; Aka P; Whittle HC; Rowland-Jones SL; Walton R
    PLoS One; 2017; 12(11):e0188307. PubMed ID: 29149205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
    Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
    Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
    Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
    Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
    Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
    Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection.
    Di Bona D; Aiello A; Colomba C; Bilancia M; Accardi G; Rubino R; Giannitrapani L; Tuttolomondo A; Cascio A; Caiaffa MF; Rizzo S; Di Lorenzo G; Candore G; Duro G; Macchia L; Montalto G; Caruso C;
    J Viral Hepat; 2017 Sep; 24(9):768-775. PubMed ID: 28211154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients.
    Joshita S; Ota M; Kobayashi H; Wakabayashi SI; Yamashita Y; Sugiura A; Yamazaki T; Tanaka E; Umemura T
    Sci Rep; 2021 Nov; 11(1):21424. PubMed ID: 34728722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
    Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
    PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
    Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
    Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-C.
    Hilton HG; Blokhuis JH; Guethlein LA; Norman PJ; Parham P
    J Immunol; 2017 Mar; 198(5):1961-1973. PubMed ID: 28122963
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective KIR-HLA interactions for HCV infection in intravenous drug users.
    Zúñiga J; Romero V; Azocar J; Terreros D; Vargas-Rojas MI; Torres-García D; Jiménez-Alvarez L; Vargas-Alarcón G; Granados-Montiel J; Husain Z; Chung RT; Alper CA; Yunis EJ
    Mol Immunol; 2009 Aug; 46(13):2723-7. PubMed ID: 19552960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunoglobulin γ marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans.
    Di Bona D; Pandey JP; Aiello A; Bilancia M; Candore G; Caruso C; Colomba C; Duro G; Ligotti ME; Macchia L; Rizzo S; Accardi G
    Immunology; 2020 Feb; 159(2):178-182. PubMed ID: 31613998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
    Roberts CH; Molina S; Makalo P; Joof H; Harding-Esch EM; Burr SE; Mabey DC; Bailey RL; Burton MJ; Holland MJ
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2744. PubMed ID: 24651768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.
    Charoudeh HN; Schmied L; Gonzalez A; Terszowski G; Czaja K; Schmitter K; Infanti L; Buser A; Stern M
    Immunogenetics; 2012 Oct; 64(10):739-45. PubMed ID: 22772778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients.
    Ursu LD; Calenic B; Diculescu M; Dima A; Stoian IT; Constantinescu I
    Int J Immunogenet; 2021 Feb; 48(1):16-24. PubMed ID: 32961633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study.
    Pan N; Jiang W; Sun H; Miao F; Qiu J; Jin H; Xu J; Shi Q; Xie W; Zhang J
    PLoS One; 2011; 6(10):e25682. PubMed ID: 21998681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.